Literature DB >> 21208601

Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

Victor J Hruby1, Minying Cai, James Cain, Joel Nyberg, Dev Trivedi.   

Abstract

The major pharmacophore for the melanocortin 1, 3, 4 and 5 receptors is the sequence -n class="Chemical">His-Phe-Arg-Trp-. There is a need for potent, biologically stable, receptor selective ligands, both agonists and antagonists, for these receptors. In this report we briefly examine the structural and biophysical approaches we have taken to develop selective agonist and antagonist ligands that can cross (or not) the blood brain barrier. Remaining questions and unmet needs are also discussed. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208601      PMCID: PMC3138524          DOI: 10.1016/j.ejphar.2010.10.109

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

Review 1.  Designing peptide receptor agonists and antagonists.

Authors:  Victor J Hruby
Journal:  Nat Rev Drug Discov       Date:  2002-11       Impact factor: 84.694

2.  D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity.

Authors:  P Grieco; P M Balse; D Weinberg; T MacNeil; V J Hruby
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

3.  Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

Authors:  Lucas Doedens; Florian Opperer; Minying Cai; Johannes G Beck; Matt Dedek; Erin Palmer; Victor J Hruby; Horst Kessler
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

4.  New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of "THIQ".

Authors:  Felikss Mutulis; Sviatlana Yahorava; Ilze Mutule; Aleh Yahorau; Edvards Liepinsh; Sergei Kopantshuk; Santa Veiksina; Kaspars Tars; Sergey Belyakov; Anatoly Mishnev; Ago Rinken; Jarl E S Wikberg
Journal:  J Med Chem       Date:  2004-08-26       Impact factor: 7.446

5.  Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity.

Authors:  M Cai; C Cai; A V Mayorov; C Xiong; C M Cabello; V A Soloshonok; J R Swift; D Trivedi; V J Hruby
Journal:  J Pept Res       Date:  2004-02

6.  Solution structures of cyclic melanocortin agonists and antagonists by NMR.

Authors:  Jinfa Ying; Katalin E Kövér; Xuyuan Gu; Guoxia Han; Dev B Trivedi; Malcolm J Kavarana; Victor J Hruby
Journal:  Biopolymers       Date:  2003       Impact factor: 2.505

7.  Real time differentiation of G-protein coupled receptor (GPCR) agonist and antagonist by two photon fluorescence laser microscopy.

Authors:  Minying Cai; Magda Stankova; Stephanie J K Pond; Alexander V Mayorov; Joseph W Perry; Henry I Yamamura; Dev Trivedi; Victor J Hruby
Journal:  J Am Chem Soc       Date:  2004-06-16       Impact factor: 15.419

8.  Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.

Authors:  Preeti Balse-Srinivasan; Paolo Grieco; Minying Cai; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2003-11-06       Impact factor: 7.446

9.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.

Authors:  Preeti Balse-Srinivasan; Paolo Grieco; Minying Cai; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2003-08-14       Impact factor: 7.446

View more
  12 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Azepinone-Containing Tetrapeptide Analogues of Melanotropin Lead to Selective hMC4R Agonists and hMC5R Antagonist.

Authors:  Olivier Van der Poorten; Krisztina Fehér; Koen Buysse; Debby Feytens; Ioanna Zoi; Steven D Schwartz; José C Martins; Dirk Tourwé; Minying Cai; Victor J Hruby; Steven Ballet
Journal:  ACS Med Chem Lett       Date:  2014-12-03       Impact factor: 4.345

3.  Trigonal scaffolds for multivalent targeting of melanocortin receptors.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Bobbi L Anglin; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Org Biomol Chem       Date:  2015-02-14       Impact factor: 3.876

4.  Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole.

Authors:  Meera E Modi; Kiyoshi Inoue; Catherine E Barrett; Kara A Kittelberger; Daniel G Smith; Rainer Landgraf; Larry J Young
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

5.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31

Review 6.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

7.  Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

Authors:  Thomas Durek; Philipp M Cromm; Andrew M White; Christina I Schroeder; Quentin Kaas; Joachim Weidmann; Abdullah Ahmad Fuaad; Olivier Cheneval; Peta J Harvey; Norelle L Daly; Yang Zhou; Anita Dellsén; Torben Österlund; Niklas Larsson; Laurent Knerr; Udo Bauer; Horst Kessler; Minying Cai; Victor J Hruby; Alleyn T Plowright; David J Craik
Journal:  J Med Chem       Date:  2018-04-11       Impact factor: 7.446

8.  Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.

Authors:  Bethany A Falls; Yan Zhang
Journal:  ACS Chem Neurosci       Date:  2018-08-13       Impact factor: 4.418

Review 9.  Alpha-melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide.

Authors:  Madhuri Singh; Kasturi Mukhopadhyay
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

10.  A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging.

Authors:  Danial Shamshirian; Mostafa Erfani; Davood Beiki; Maliheh Hajiramazanali; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.